Expansion Study of ALT001 in Patients With Multiple System Atrophy

Summary

This is an open-label, single-center, prospective, single-arm clinical study. The primary objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of ALT001 in the treatment of patients with multiple system atrophy (MSA) in a real-world setting.

Timeline

Start

2026-05-06

Primary completion

2027-10-30

Completion

2027-10-30

Drugs

Indications